The Effects of Lokomat Virtual Reality Applications on Balance and Gait in Stroke Patients
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Stroke is an important health problem worldwide. Emotional, cognitive, sensory and motor problems occur with stroke. Motor problems are especially balance and walking problems and they are related to each other. So balance and gait rehabilitation are primary goals in stroke.
Although the first study to support the efficacy of Lokomat is that Lokomat is superior to conventional physiotherapy in walking, there are also studies reporting that there is no difference between the effects of Lokomat and conventional physiotherapy and that conventional physiotherapy is superior. In the light of all these studies, the effectiveness of applying robotic systems together with conventional physiotherapy is widely accepted.
Robot Assisted Walking Training has many components such as guiding force, walking speed, body weight support. Virtual reality is one of these components and there is literature in which Lokomat virtual reality applications are effective on balance and walking. Although the virtual reality effect is emphasized for Lokomat, there is a lack of literature on the specific effect of different virtual reality applications. In our study, it was aimed to examine the changes caused by different Lokomat virtual reality applications in the spatiotemporal parameters of balance and gait.
Method: This study was conducted to examine the effects of Lokomat VR applications on balance and spatiotemporal parameters of gait in patients with chronic stroke; It is a prospective, randomized controlled, single-blind study. The study will be carried out in a single-blind manner, and the evaluator will not know which group the individual is in. 56 individuals with chronic stroke included our study. All individuals have been informed about the study and read and signed the consent form stating that they voluntarily participated in the study. For balance evaluation we used Berg Balance Scale and Huber 360 device, which measures postural stability and limits of stability. And for gait evaluation we used 10 MWT, 6 MWT and spatiotemporal gait analysis for C-Mill VR+.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Ankara, Kalkun, 06000
- Ankara City Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Clinical diagnosis is stroke
- The time period have to be chronic period (+6 months)
- The patient must have the ability to walk with or without support
- The patiens should be able to understand Lokomat exercises
Exclusion Criteria:
- Any condition that may prevent walking with Lokomat
- Not volunteering to participate in the study
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Lokomat Group I (Endurance)
|
-Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
|
|
Eksperimentel: Lokomat Group II (Attention and Motivation)
|
-Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
|
|
Eksperimentel: Lokomat Group III (Activity Timing)
|
-Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
|
|
Andet: Control
-Only Conventional Physiotherapy
|
-Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in 6 MWT
Tidsramme: 6 weeks after treatment
|
6 Minutes Walk Test is a test using for walking distance.
We evaluated the change in walking distance with 6 MWT.
|
6 weeks after treatment
|
|
Change in 10 MWT
Tidsramme: 6 weeks after treatment
|
10 MWT is a test using for evaluate the gait speed.
Gait speed is a spatiotemporal parameter.
|
6 weeks after treatment
|
|
Change in BBS
Tidsramme: 6 weeks after treatment
|
Berg Balance Scale used for balance assesment.
The scale consists of 14 items and each item gets a score between 0-4.
As a result, the person evaluated gets a score between 0-56 on the berg balance scale.
A higher score means the person has better balance skills.
|
6 weeks after treatment
|
|
Change in Limits of Stability
Tidsramme: 6 weeks after treatment
|
Limits of Stability (LoS) are defined as the points at which the center of gravity (CoG) approaches the limits of the base of support (BoS) and a correction strategy is required to return the center of mass (CoM) to within the BoS.
In other words, LoS is the amount of maximum excursion an individual is able to intentionally cover in any direction without losing his/her balance or taking a step.
We used Huber 360 device to evaluate the LoS.
|
6 weeks after treatment
|
|
Change in Spatiotemporal Gait Analysis
Tidsramme: 6 weeks after treatment
|
Spatiotemporal gait analysis gives spatial (distance) parameters along with temporal (time) parameters.
|
6 weeks after treatment
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Spatial Symmetry
Tidsramme: 6 weeks after treatment
|
It is the ratio of the hemiplegic side step lenght to the non-hemiplegic side step lenght.
|
6 weeks after treatment
|
|
Change in Temporal Symmetry
Tidsramme: 6 weeks after treatment
|
For temporal symmetry we used the description "Gait Symmetry".
Gait symmetry is calculated by the ratio of the hemiplegic side sway phase to the hemiplegic side stance phase ratio and the ratio of the non-hemiplegic side sway phase to the non-hemiplegic side stance phase ratio.
|
6 weeks after treatment
|
|
Change in Postural Stability
Tidsramme: 6 weeks after treatment
|
Postural stability refers to the ability to maintain your body in a position to effectively complete a task or demand, using large muscle groups at the shoulders, trunk, and hips.
We used Huber 360 device to evaluate the postural staiblity.
The assesments were combination of opened and closed eyes.
We recorded the COP vellocity and area.
|
6 weeks after treatment
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Lokomat VR
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Robot Asisted Gait Training with Lokomat (Endurance)
-
IRCCS Eugenio MedeaAfsluttetCerebral Parese | Erhvervet hjerneskadeItalien